Two cancer research studies reveal essential role of neutrophils in immunotherapy

Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.

ESMO 2016: Pembrolizumab new option for first line treatment of

Scientists unravel tumor neutrophil complexity, discover

ESMO 2016: Ceritinib provides longer PFS than chemo in trial of

Study identifies how microbiome may affect pancreatic cancer

Cancer discovery could revive failed treatments for solid tumours

ASCO GI: Less chemotherapy may have more benefit in rectal cancer

Surprise Finding Shows That Neutrophils Can Be Key Antitumor

Two cancer research studies reveal essential role of neutrophils

Researchers uncover potential biomarkers of positive response to

Two cancer research studies reveal essential role of neutrophils

Scientists unravel tumor neutrophil complexity, discover

ASCO 2023: Immunotherapy for brain cancer metastases shows

Turbocharging the killing power of immune cells against cancer